Selvita Signs a Drug Discovery Services Contract With Rottapharm Madaus
“We are delighted to start an FTE-based collaboration with Selvita. We are keen to take advantage of Selvita’s know-how to support the progression of our drug discovery pipeline" - said Luigi Stasi, Rottapharm’s Director of Medicinal Chemistry Department.
"This project is an immense chance for Selvita to show the great potential of our Computational Chemistry and Chemistry Departments. Working for Rottapharm Madaus on this project will enable us to take a full advantage of our highly skilled scientists and new facilities, and I truly believe we can deliver exactly what Rottapharm Madaus needs” - said Pawel Przewiezlikowski, Selvita’s CEO.
Organizations
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.